Trial intelligence / Profile preview

Itopride effects on gastric function in healthy volunteers

NCT00308399Phase 3Completed

Sponsor
Mayo Clinic
Start
Nov 2005
Primary completion
Jun 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of itopride in functional dyspepsia (FD), sponsored by Mayo Clinic. Started Nov 2005; status: completed.

02

Drugs

itopride
03

Conditions

functional dyspepsia (FD)

Beyond the preview

Go deeper on NCT00308399.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00308399.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call